Recently, Shanghai FTZ Fund has invested in leading domestic enterprises in the field of Panel gene detection. OrigiMed focuses on international R&D and clinical application transformation in tumor field. Its business mainly includes clinical detection service, pharmaceutical enterprise cooperation business, internet hospital platform business, etc.
